Minovia
Tirat Carmel
About Minovia
is a biotechnology research company focusing on treatment for mitochondrial disease. The company uses a cell therapy to treat such disease through its Mitochondrial Augmentation Therapy (MAT) platform. The company's platform repairs damaged mitochondrial DNA by using autologous stem cells enriched with blood-derived mitochondria. Minovia was founded in 2011 and is based in Tirat Carmel, Hefa, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $350.0K
- Funding stage: M&A
- Last round: Grant (Aug 2025)
- Website: minovia.com
- Phone: +972-747039954
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/minovia-78953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.